Lidocaine Infusion With ANI Monitoring in Spine Surgery.
Status:
Not yet recruiting
Trial end date:
2023-03-31
Target enrollment:
Participant gender:
Summary
To evaluate the analgesic effect of intraoperative continuous lidocaine infusion (1.5 mg/kg/h
(ideal body weight)) in combination of analgesia nociception index and depth of anesthesia
monitors guided anesthetics adjustment on enhanced recovery after surgery (ERAS) in patients
undergoing elective lumbar spine surgery (≥2 sessions).
Phase:
Phase 4
Details
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital